Home » Topics » Disease categories and therapies » Urology

Urology
RSS

IP-751 demonstrates efficacy against bladder irritation in vivo

May 22, 2006

DDP-225 improves bladder irritation and capacity in animal models

May 22, 2006

Activity of BXL-628 indicative of efficacy in overactive bladder

May 22, 2006

More positive data reported for Nymox's BPH drug candidate

May 19, 2006

Effect of sildenafil on peak systolic velocity a mechanism of erection improvement

May 19, 2006

GYKI-16084 improves symptoms in benign prostatic hyperplasia

May 19, 2006

SOU-001 development discontinued at Sosei

May 17, 2006

Threshold changes TH-070 development program

May 16, 2006

Elocalcitol shows efficacy in overactive bladder phase II study

May 15, 2006

Urief launched in Japan for urinary disturbance associated with enlarged prostate

May 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...